EU backs compulsory licensing for COVID vaccines
The European Union has submitted a new proposal to the World Trade Organisation, which backs compulsory licensing agreements for COVID-19 vaccines when negotiations fail.
Endo, Impax face class-action over antitrust claims
Endo International and Amneal Pharmaceuticals’ subsidiary, Impax Laboratories, have failed to prevent antitrust claims over a patent settlement from going to trial.
Cannabis company to face ‘Kool’ menthol dilution claims
Cannabis company Capna has failed to convince a California district court judge to dismiss a trademark suit alleging it infringed a tobacco company’s cigarette marks.
Clarus succeeds in invalidating four Lipocine testosterone patents
Clarus Therapeutics has convinced a US court to invalidate four Lipocine testosterone booster patents it was accused of infringing.
AbbVie says bar for ‘sham litigation’ is too low
AbbVie has again urged the US Supreme Court to save it from claims of filing sham litigation to block competition for testosterone treatment AndroGel.
Federal Circuit upholds another ITC decision in 10X vs Bio-Rad
The US Court of Appeals for the Federal Circuit has upheld a decision from the US International Trade Commission that found 10X Genomics infringed on two Bio-Rad Laboratories gene sequencing patents.
Bardehle opens Paris life sciences practice with two hires
Munich-based firm Bardehle Pagenberg has established a life sciences practice at its Paris office with two recent hires.
Japan’s IP office upholds CRISPR patent and allows third
A CRISPR patent filed by scientist Emmanuelle Charpentier alongside the Regents of the University of California and the University of Vienna has been upheld by the Japan Patent Office.
UC Berkeley auctions Nobel Prize invention materials as NFTs
A non-fungible token for a Nobel Prize-winning cancer immunotherapy invention has been minted ahead of an auction tomorrow arranged by the University of California, Berkeley.
President Xi supports COVID-19 waiver
President Xi Jingping has announced his support for waiving IP rights for COVID-19 vaccines.
